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Figure S1. Indel analysis of the targeted Lmnb1 and Actb loci in mouse HSPCs, 
Related to Figure 1. Activated Cas9-HSPCs were electroporated with sgLmnb1 (A) or 
sgActb (B). 3 days post gene editing, the LSK cells were sorted and the targeted 
sequences were amplified by PCR, cloned and sequenced. PAM signal, sgRNA and 
Stop codon are indicated in red, blue and magenta, respectively. The pie charts and 
histograms show the efficiencies of NHEJ events and type of NHEJ mutations. (C) 
Summary of HR efficiency in the targeted loci for the data shown in main Figure 1D. 
Quantification of HR frequency represent means ± SD (**p<0.01, Mann-Whitney test). 








	   	  
Figure S2. Quantification of HR and NHEJ frequencies in the targeted HSPCs, 
Related to Figure 1. (A) Sequences amplified from the Lmnb1 (left) and Actb (right) loci 
in the targeted HSPCs that were treated with sgRNAs only (top) or sgRNA and AAV-DJ 
donor vectors (bottom). The sequences in orange and blue were corrected by HR. 
Frequencies of frame-shift (blue) and in-frame (black) mutations in NHEJ events were 
quantified (right panel, bar graphs). (B) Experimental scheme to determine mono- and 
bi-allelic HR events using PCR genotyping for individual reporter+ colonies. Two days 
post targeting, the reporter+ LSK cells were sorted and colony forming assays were 
performed. Ten days later, single colonies were picked for genotyping PCR. The 
targeted Lmnb1 (left) and Actb (right) loci were amplified using the primer sets indicated 




	   	  
  
Figure S3. Sequencing of on- and off-target sites of sgLmnb1 and sgActb, Related 
to Figure 2. The on- and (top 5) off-target sites of sgLmnb1 (left) and sgActb (right) 
were amplified from untreated HSPCs (control) or HSPCs that were treated with the 
indicated sgRNAs and sequenced 3 days post editing. The dashed red lines highlight 
the PAMs or alternative PAMs (aPam), the adjacent black lines indicate the on/off-
target, and the dashed magenta lines indicate the predicted potential cut sites. 
  
	  
	   	  
Figure S4. HR-mediated gene insertion in wild-type HSPCs, Related to Figure 2. 
Activated-Sca1+ HSPCs from C57BL/6 mice were electroporated with RNPs containing 
sgLmnb1 (A) or sgActb (B) and subsequently infected with the indicated AAV-DJ donor 
vectors. The frequencies of mCherry+ (A) and BFP+ (B) LSK cells were analysed by flow 
cytometry 3 days post targeting. 
  
	  
	   	  
 
 
Figure S5. Comparison of AAV-DJ and AAV6 and titration of AAV-DJ vectors and 
sgRNA, Related to Figure 3. (A) Activated Cas9-HSPCs were electroporated with the 
indicated sgRNAs and infected with AAV-DJ or AAV6 donor vectors at a MOI of 1x106 
GC/cell. Using the gating strategy, the frequencies of mCherry+ and BFP+ cells in the 
targeted Cas9-HSPCs were quantified. Data are based on 3 independent experiments. 
(B) Activated Cas9-HSPCs were electroporated with sgLmnb1 and infected with the 
indicated doses of rAAV-DJ-Lmnb1 donor virus. The cell viability (as measured by 
DAPI-) and the HR efficiency in LSKs were determined by flow cytometry. (C) Activated 
Cas9-HSPCs were electroporated with the indicated doses of sgLmnb1 (upper panel) or 
sgActb (lower panel) before infection with rAAV-DJ-Lmnb1 or rAAV-DJ-Actb donor 
viruses (MOI of 2x106 GC/cell). The frequencies of mCherry+ and BFP+ cells were 
determined by flow cytometry. The histogram summarizes the frequencies of BFP+ cells 
in the Actb-targeted HSPCs from 3 independent experiments. Data show means ± SD 
(** p<0.01, Mann-Whitney test); ns: not significant. 
  
	  




Figure S6. HR efficiencies and proliferation rates in mouse LSK subsets, Related 
to Figure 3. (A) Sca1+ Cas9-HSPCs were labeled with CellTrace violet and activated. 
Proliferation rates were determined by flow cytometry on day 2 and 4 post labeling. 
Gating on the HSC/MPP1 (R1: CD48-CD150+), MPP2 (R2: CD48+CD150+) and MPP3/4 
(R3: CD48+CD150-) LSK subsets, cell division was determined by analysing the dilution 
of CellTrace violet. (B) 2 days after stimulation, the labeled cells were electroporated 
with sgLmnb1 and infected with the AAV-DJ-Lmnb1 donor vectors. FACS analysis 
shows numbers of cell division in each LSK subset. Graph summarizes the fractions of 
cells in each LSK subset that underwent the indicated number of cell division. (C) FACS 
analysis shows frequencies of gene knock-in (mCherry+) versus cell division in the total 













	   	  
 
 
Figure S7. Generation of non-viral dsDNA and ssDNA donor templates, Related to 
Figure 4. (A) Scheme of gene insertion into the Lmnb1 locus using the indicated donor 
template types with 0.8 kb homology arms. (B) To generate Lmnb1-mCherry dsDNA 
donor templates, the XhoI/NotI-flanked Lmnb1-T2A-mCherry fragment was digested 
with XhoI and NotI restriction enzymes. This fragment was then separated on an 
agarose gel and purified by gel extraction. To generate the Lmnb1-mCherry ssDNA 
(antisense and sense), a nicking nuclease (Nb. BsrDI) recognition site was added into 
the 5’ end of Lmnb1-T2A-mCherry fragment. Depending on the orientation of the nicking 
nuclease recognition site, the antisense or sense ssDNA is produced. The nicking 
plasmids were digested with NotI and nicking Nb. BsrDI restriction enzymes. The 
digested plasmids were then purified by ethanol precipitation and resuspended in 
denaturing buffer. The digested plasmids were denatured at 70°C for 10 min and chilled 
on ice for 1 min. The ssDNA HR templates were separated on agarose gel, and the 
expected band was excised and purified by gel extraction kit.  (C) Gel of the obtained 




	   	  
  
Figure S8. The targeted HSPCs contribute to the immune system, Related to 
Figure 5. (A) Frequencies of GFP+ donor cells in the bone marrow and spleen of the 
recipients after 8 (black, n=4) and 16 weeks (orange, n=3) of reconstitution. (B) Gating 
strategy to analyse the T, B, NK, and Gr-1+ cells among GFP+ donor cells in the bone 
marrow and spleen of the recipient animals 8 weeks post transplantation. (C) 
Histograms showing the percentages of mCherry+ cells among T cells, B cells, NK cells 
and Granulocytes (Gr-1+) in the bone marrow (upper row) and spleen (lower row) of the 
recipient animals after 8 and 16 weeks of reconstitution. (D) Summary of percentages of 
mCherry+ cells among the indicated immune cell lineages in the bone marrow (left) and 
spleen (right) of the recipient animals after 8 weeks (black, n=4) and 16 weeks (orange, 
n=3) post reconstitution. (E) Graph summarizes frequencies of GFP+ donor cells in the 
blood of the recipient mice (n=4) that reconstituted with either sgLmnb1-treated (black) 
or sgLmnb1/AAV-DJ-treated LSK cells (grey), at 2 and 4 weeks post reconstitution.   
  
	  
	   	  
 
 
Figure S9. Secondary reconstitution of the Lmnb1-targeted HSPCs, Related to 
Figure 5. (A) Experimental scheme of secondary transplantation of the Lmnb1-targeted 
HSPCs into irradiated Rag2-/-cᵧ-/- mice. The targeted Cas9-HSPCs (GFP+) were sorted 
from the recipient animals 8 weeks post primary reconstitution. These cells were then 
transplanted into secondary recipients (n=4). Immune cell lineages were analysed by 
flow cytometry 5 weeks post secondary reconstitution. (B) FACS analysis shows the 
percentage of GFP+ donor and knocked-in mCherry+ cells in the bone marrow and 
spleen of the secondary recipients. Percentages of T, B, NK, and Gr-1+ cells among 
mCherry+ cells were analyzed by gating on mCherry+ cells. (C) Summary of data based 
on 4 recipient mice 5 weeks post secondary reconstitution.  
  
	  
	   	  
 
 
Figure S10. HR and NHEJ frequencies in Rag2-repaired HSPCs, Related to Figure 
6. Scheme of a Neo-disrupted Rag2 allele including the TK promoter, neomycin and the 
polyA sequence. The sgRNA target sequences of sg-1 and sg-2 are highlighted in blue 
and the respective PAM sequences in red. Lower panel: sequencing data of the 
amplified targeted loci showing correct HR (HR, magenta) and indel patterns in the cells 
that received RNPs only (top) or RNPs and AAV-DJ donor vectors (bottom).  
	  
	   	  
 
Figure S11. Molecular analysis of Rag2-repaired NK and B cells, and secondary 
reconstitution of Rag2-repaired HSPCs, Related to Figure 7. (A) HR frequencies in 
NK cells from 2 recipient animals (#92 and #93) 8 weeks post reconstitution. gDNA was 
amplified by PCR using the primer sets as indicated in main Figure 6A. The numbers 
reflect the HR efficiency based on band quantification. (B) HR frequencies in B cells 
from 5 recipient animals (#67, 68, 92, 93 and 94) 8 weeks post reconstitution. The 
targeted locus was amplified using the PCR primers as indicated in the scheme. As a 
control, gDNA from a Rag2-/- mouse was used. (C) Indel diversity analysis in B cells. 
The frequencies of HR and NHEJ events were quantified by sequencing (pie chart). In 
the cases of NHEJ, the diversity of indels was analysed. (D) Experimental scheme of 
secondary reconstitution of Rag2-repaired HSPCs. The LSK cells, including host and 
donor HSPCs, were sorted from the recipient animals 8 weeks post primary 
reconstitution and transplanted into secondary recipients. 5 weeks post secondary 
reconstitution, B and T cells were analysed in the blood, bone marrow and spleen of the 
recipients. Summary of the data from blood, bone marrow (BM) and spleen of 4 
recipient animals 5 weeks post secondary reconstitution.  
 
	  
	   	  
Table S1. Sequences of primers used in this study, related to Star Methods.  
 
PCR Primers Sequence (5'-3') Related to Figures 
Lmnb1-T7-For AATCTTAACTGTTTACAGGCCTAGGTCAGCT 
















Figure 2 and Figure S3 
L-OT-1-Rev CCAGGACCACCAGACCAGGGATGGCACTGT 
L-OT-2-For GGCTGCTACATACGTGCCTGTGAGTGCCTC 
Figure 2 and Figure S3 
L-OT-2-Rev CCTTCCTAAGTGGTTTCCTTCAGCTCTGCT 
L-OT-3-For AGGACTGCCTTGTGCCAGATCTGTAAGAGA 
Figure 2 and Figure S3 
L-OT-3-Rev GTATTGGACTCCTAGAAGCAGGTGGGACAA 
L-OT-4-For CACTGGCACTAGCTGTTTCATCTTCCTGCC 
Figure 2 and Figure S3 
L-OT-4-Rev GCTCTCAGCTATGGCTCCAGCATCAAGCCT 
L-OT-5-For GAGAAAGTGCTTTACAGCTGGATCTCACGA 
Figure 2 and Figure S3 
L-OT-5-Rev ATCAATGGTCAACACCGGGTACAATTGCGT 
A-OT-1-For GGATGTTTGCTTCAACCGACTGCCTTCGCC 
Figure 2 and Figure S3 
A-OT-1-Rev CATGTACCCAGGCATTGCTGACAGGATGCA 
A-OT-2-For CCAGTTTTTAAATCTCGAGTCCAAAGCAC 
Figure 2 and Figure S3 
A-OT-2-Rev CAGGCATTGCTGACCTGATGCAGGAGATCA 
A-OT-3-For ACAGGCGCCGGCTGCAGTGGCGGCGATGGA 
Figure 2 and Figure S3 
A-OT-3-Rev GGAACACGCAGGCACGTGACACTCTTGTCT 
A-OT-4-For AAGAAGCCATGCCAGGGTTATCTCAGGGTT 
Figure 2 and Figure S3 
A-OT-4-Rev CCTAGTTGATGAGCACAGTGTGGGTGACCT 
A-OT-5-For TGCGCAAGTTAGGTTTTGTCAAAGAAAGGGT 








Figure 6, Figure 7, Figure S10 and Figure 
S11 
Rag2-WT-Rev ACTATACACCACGTCAATGGAATGGCCGTA 
Rag2-Neo/NHEJ-
Rev ACAAGGGCAGTGTGGTTTTCAAGAGGAAGC 
 
